Exome sequencing is revolutionizing Mendelian disease gene identification. disease has received a increase in the last year or two by the launch of new technology that enable the sequencing of DNA at a higher throughput and at lower costs than previously feasible [4]. Although traditional gene mapping approaches (such as for example karyotyping [5], linkage evaluation [6] homozygosity mapping [7] and duplicate amount variation (CNV) evaluation [8]) have resulted in great insights into Mendelian disease in the last few decades (Body ?(Figure1),1), they cannot detect all types of genomic variation (Desk ?(Desk1).1). The strategy applied would depend on if the disease is certainly, for instance, caused by one nucleotide mutations or by CNVs, which is certainly challenging to predict beforehand. Furthermore, mapping techniques would often not really reduce the amount of applicant genes sufficiently for simple follow-up by Sanger sequencing [9]. For instance, genome-wide one nucleotide polymorphism evaluation in a big Dutch pedigree with autosomal-dominant familial exudative vitreoretinopathy (FEVR, MIM 613310), a retinal disorder, determined a linkage peak around 40 Mb on chromosome 7, that contains a lot more than 300 genes [10]. Also after adding linkage data from another FEVR Paclitaxel pontent inhibitor family members the spot was still too large for straightforward disease-gene identification, and Sanger sequencing of a few candidate genes did not identify causative mutations. Next generation sequencing (NGS) has the potential to identify all kinds of genetic variation at base-pair resolution throughout the human genome in a single experiment. This can be performed much faster and more cost efficiently than with traditional techniques (the sequencing of a genome by traditional techniques needed many years and cost millions of dollars, whereas NGS technology can sequence a genome for less than $7,000 and within a week [11]). This enables the detailed genomic analysis of large numbers of patients [12]. In the case of the two families with FEVR, we [10] used next generation sequencing to investigate the entire coding sequence of the 40-Mb region in a single affected individual from the first family and identified mutations in tetraspanin 12 ( em TSPAN12 /em ) to be the cause of FEVR in both families and in three additional families. For most Mendelian disorders, however, there is no disease locus known and an unbiased approach is required. Table 1 Mendelian disease gene identification approaches thead th align=”left” rowspan=”1″ colspan=”1″ Approach /th th align=”left” rowspan=”1″ colspan=”1″ Applies to /th th align=”left” rowspan=”1″ colspan=”1″ Advantages /th th align=”left” rowspan=”1″ colspan=”1″ Disadvantages /th /thead Candidate geneAny diseaseEasy to perform Paclitaxel pontent inhibitor for one or two genes; requires no mapping, can directly identify the causative variant/mutationRelies heavily on current biological knowledge; success rate very lowGenetic mapping by karyotypingAny diseaseEasy to perform; no familial cases required; can detect (large) balanced eventsLow resolution, only detects large chromosomal aberrations; mutation detection requires second stepGenetic mapping by linkage analysisInherited diseaseEasy to performRequires large families, often identifies large loci; mutation detection requires second stepGenetic mapping by homozygosity mappingRecessive monogenic diseasesSmall families can be usedMost useful for consanguineous families; often identifies large loci; mutation detection requires second stepGenetic mapping by CNV analysisMonogenic/monolocus diseaseHigh resolution CNV screening; no familial cases required; can potentially identify small lociOnly investigates CNVs; cannot detect balanced events, no base-pair resolution; mutation detection requires second stepWhole exome sequencing (WES)Any diseaseBase-pair resolution exome-wide; detects most types of genomic variation; can directly identify the causative variant/mutationUnable to detect non-coding variants; limited resolution for CNVs and other structural variation; coverage variability due to enrichment process; relatively expensiveWhole genome sequencing (WGS)Any diseaseBase-pair resolution genome-wide; detects all types of Paclitaxel pontent inhibitor genomic variation; can directly identify the causative variant/mutationData analysis complex; even more expensive than exome sequencing POLD4 Open in a separate window Open in a separate window Figure 1 A timeline illustrating technological breakthroughs and hallmark publications for Mendelian disease gene identification. (a) The main historical.
Recent Posts
- A ratio of group mean organ weight to group mean body weight (mean organ wt/mean body wt) was calculated for all those groups
- J
- This results in the predicted trajectories that are compared with the data
- Fourth, in WC5 cells transformed by temperature-sensitive v-Src and expressing E-cadherin ectopically, immunoprecipitates of PTP from lysates of cells cultured in the nonpermissive temperature contained coprecipitating cadherin, whereas in the permissive temperature the levels of connected cadherin were reduced substantially (Fig
- Furthermore, we completed a label free quantification (LFQ) of protein using MaxQuant software program (version 1
Archives
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- February 2018
- January 2018
- November 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
Categories
- 11-?? Hydroxylase
- 11??-Hydroxysteroid Dehydrogenase
- 14.3.3 Proteins
- 3
- 5-HT Receptors
- 5-HT Transporters
- 5-HT Uptake
- 5-ht5 Receptors
- 5-HT6 Receptors
- 5-HT7 Receptors
- 5-Hydroxytryptamine Receptors
- 5??-Reductase
- 7-TM Receptors
- 7-Transmembrane Receptors
- A1 Receptors
- A2A Receptors
- A2B Receptors
- A3 Receptors
- Abl Kinase
- ACAT
- ACE
- Acetylcholine ??4??2 Nicotinic Receptors
- Acetylcholine ??7 Nicotinic Receptors
- Acetylcholine Muscarinic Receptors
- Acetylcholine Nicotinic Receptors
- Acetylcholine Transporters
- Acetylcholinesterase
- AChE
- Acid sensing ion channel 3
- Actin
- Activator Protein-1
- Activin Receptor-like Kinase
- Acyl-CoA cholesterol acyltransferase
- acylsphingosine deacylase
- Acyltransferases
- Adenine Receptors
- Adenosine A1 Receptors
- Adenosine A2A Receptors
- Adenosine A2B Receptors
- Adenosine A3 Receptors
- Adenosine Deaminase
- Adenosine Kinase
- Adenosine Receptors
- Adenosine Transporters
- Adenosine Uptake
- Adenylyl Cyclase
- ADK
- Antivirals
- AP-1
- Apelin Receptor
- APJ Receptor
- Apoptosis
- Apoptosis Inducers
- Apoptosis, Other
- APP Secretase
- Aromatic L-Amino Acid Decarboxylase
- Aryl Hydrocarbon Receptors
- ASIC3
- AT Receptors, Non-Selective
- AT1 Receptors
- AT2 Receptors
- Ataxia Telangiectasia and Rad3 Related Kinase
- Ataxia Telangiectasia Mutated Kinase
- ATM and ATR Kinases
- ATPase
- ATPases/GTPases
- ATR Kinase
- Atrial Natriuretic Peptide Receptors
- Aurora Kinase
- Autophagy
- Autotaxin
- AXOR12 Receptor
- c-Abl
- c-Fos
- c-IAP
- c-Raf
- C3
- Ca2+ Binding Protein Modulators
- Ca2+ Channels
- Ca2+ Ionophore
- Ca2+ Signaling
- Ca2+ Signaling Agents, General
- Ca2+-ATPase
- Ca2+Sensitive Protease Modulators
- Caged Compounds
- Calcineurin
- Calcitonin and Related Receptors
- Calcium (CaV) Channels
- Calcium Binding Protein Modulators
- Calcium Channels
- Calcium Channels, Other
- Calcium Ionophore
- Calcium-Activated Potassium (KCa) Channels
- Calcium-ATPase
- Calcium-Sensing Receptor
- Calcium-Sensitive Protease Modulators
- CaV Channels
- Non-selective
- Other
- Other Subtypes
- Uncategorized